Fluorometholone/Sulfacetamide Sodium

氟米龙/磺胺醋酰钠

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFluorometholone/Sulfacetamide Sodium
Drug Alias Name磺胺醋酰钠/氟米龙Sulfacetamide Sodium/FluorometholoneFluorometholone and Sulfacetamide SodiumSulfacetamide Sodium and FluorometholoneFML-S
ClassificationSmall molecules
Mechanisms of ActionDihydropteroate synthase inhibitorsGlucocorticoid receptor agonists
TargetsGlucocorticoid receptorDihydropteroate synthase
Therapy Area/IndicationsEye Infections
Global Approved IndicationsEye Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1989/09/29
Country/TerritoryUnited States
CombinationsYes FluorometholoneSulfacetamide Sodium
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllergan Plc
Active IndicationsN/A
Inactive IndicationsEye Infections

Other Information

ATC CodeN/A
Related LinksN/A